Pages that link to "Q46960414"

The following pages link to Imaging the Abeta-related neurotoxicity of Alzheimer disease (Q46960414):

Displaying 47 items.

• Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. (Q27312746) (← links)
• Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48 (Q28297520) (← links)
• R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures (Q30461090) (← links)
• Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. (Q30483032) (← links)
• Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability (Q30857122) (← links)
• Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life (Q33292558) (← links)
• Pinpointing synaptic loss caused by Alzheimer's disease with fMRI (Q33511727) (← links)
• Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders (Q33555684) (← links)
• Mechanisms of age-related cognitive change and targets for intervention: epigenetics. (Q33565018) (← links)
• Anterior-posterior cerebral blood volume gradient in human subiculum (Q33688290) (← links)
• Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease (Q33709263) (← links)
• The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. (Q33839388) (← links)
• Increased hippocampal CA1 cerebral blood volume in schizophrenia (Q34079242) (← links)
• Polyamine pathway contributes to the pathogenesis of Parkinson disease (Q34165462) (← links)
• A pathophysiological framework of hippocampal dysfunction in ageing and disease (Q34214060) (← links)
• Hippocampal subregions differentially associate with standardized memory tests (Q34434380) (← links)
• Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults (Q34441691) (← links)
• Retromer in Alzheimer disease, Parkinson disease and other neurological disorders (Q34462122) (← links)
• A summary risk score for the prediction of Alzheimer disease in elderly persons (Q34747831) (← links)
• Age-related memory deficits linked to circuit-specific disruptions in the hippocampus (Q35008262) (← links)
• Analysis of hippocampal gene expression profile of Alzheimer's disease model rats using genome chip bioinformatics (Q35148818) (← links)
• The absence of the calcium-buffering protein calbindin is associated with faster age-related decline in hippocampal metabolism. (Q35194522) (← links)
• Pattern separation in the hippocampus (Q35242845) (← links)
• Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease (Q35619936) (← links)
• Increased hippocampal blood volume and normal blood flow in schizophrenia. (Q35629893) (← links)
• Hippocampal neurogenesis: Learning to remember (Q36788646) (← links)
• Impact of aging brain circuits on cognition (Q36960839) (← links)
• Amyloid-β induces synaptic dysfunction through G protein-gated inwardly rectifying potassium channels in the fimbria-CA3 hippocampal synapse. (Q37043451) (← links)
• How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia (Q37388973) (← links)
• Linking hippocampal structure and function to memory performance in an aging population (Q37424713) (← links)
• Memory performance is related to amyloid and tau pathology in the hippocampus (Q37445497) (← links)
• Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver (Q37665156) (← links)
• The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update (Q37998086) (← links)
• Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease (Q38118901) (← links)
• GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease (Q38225536) (← links)
• Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition. (Q41466803) (← links)
• Age-related changes in Egr1 transcription and DNA methylation within the hippocampus. (Q41834725) (← links)
• In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through? (Q42118376) (← links)
• Multi-voxel pattern analysis in human hippocampal subfields (Q42418639) (← links)
• Quantitative rapid steady state T1 magnetic resonance imaging for cerebral blood volume mapping in mice: Lengthened measurement time window with intraperitoneal Gd-DOTA injection. (Q44839200) (← links)
• Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology (Q47153423) (← links)
• Mapping the structural and functional network architecture of the medial temporal lobe using 7T MRI. (Q47328350) (← links)
• Investigation of cognitive circuits using steady-state cerebral blood volume and diffusion tensor imaging in patients with mild cognitive impairment following electrical injury (Q47833308) (← links)
• Neuroimaging to assess safety and efficacy of AD therapies (Q48394858) (← links)
• Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. (Q51748790) (← links)
• A guide to using functional magnetic resonance imaging to study Alzheimer's disease in animal models. (Q54986305) (← links)
• Brain regions vulnerable and resistant to aging without Alzheimer's disease (Q98161887) (← links)